Matrix metalloproteinase levels in acute aortic dissection, acute pancreatitis and other abdominal pain

Emergency Medicine Journal

Volumn 26, Issue 10, 2009, Pages 715-718

  Wen, T ^a   Liu, L ^a   Xiong, G Z ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; LIPOPROTEIN A;

ABDOMINAL PAIN; ACUTE ABDOMEN; ACUTE DISEASE; ACUTE PANCREATITIS; ADULT; AORTA DISSECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; TURBIDIMETRY;

ABDOMEN, ACUTE; ABDOMINAL PAIN; ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PANCREATITIS;

EID: 70349317468     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2008.067645     Document Type: Article

References (13)

1. Koullias GJ, Ravichandran P, Korkolis DP, et al. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissection. Ann Thorac Surg 2004;78:2106-2111 (Pubitemid 39556304)
2. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-129
3. Sangiorgi G, D'Averio R, Mauriello A, et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001;104:I288-95. (Pubitemid 32884818)
4. Sangiorgi G, Trimarchi S, Mauriello A, et al. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med (Hagerstown) 2006;7:307-315 (Pubitemid 44145632)
5. Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol 2008;14:675-684
6. Schillinger M, Domanovits H, Ignatescu M, et al. Lipoprotein (a) in patients with aortic aneurysmal disease. J Vasc Surg 2002;36:25-30. (Pubitemid 41122884)
7. Andrié R, Maylahn M, Braun P, et al. C-reactive protein in coronary plaques - prevalence with acute coronary syndrome (in German). Z Kardiol 2002;91:913-920 (Pubitemid 35454208)
8. Schillinger M, Domanovits H, Bayegan K, et al. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 2002;28:740-745 (Pubitemid 34639487)
9. Solberg A, Holmdahl L, Falk P, et al. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. Int J Colorectal Dis 2008;23:611-618
10. Aynaci M, Tuncyurek P, Nart D, et al. Does matrix metalloproteinase activity predict severity of acute pancreatitis? Aust NZ J Surg 2006;76:801-804
11. Chen P, Yuan Y, Wang S, et al. Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis. Tohoku J Exp Med 2006;208:261-266 (Pubitemid 43300005)
12. Derosa G, D'Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels 2007;22:361-370 (Pubitemid 350201431)
13. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-1066 (Pubitemid 29436454)